Skip to main content

Please wait ...

Sibyl Swift

VP of Scientific & Regulatory Affairs

CbdMD


Prior to joining cbdMD, Dr. Swift was the Senior VP for Scientific & Regulatory Affairs at the Natural Products Association (NPA) where she led the association’s work in Codex, the Supplement Safety & Compliance Initiative (SSCI), and FDA policy. Prior to her time at the NPA, Dr. Swift was the associate director for research and strategy at the US Food and Drug Administration (FDA), where she directed the Office of Dietary Supplement Programs research agenda and worked closely on office policy and enforcement.

Dr. Swift will oversee the CbdMD’s GMP compliance, internal product quality and safety initiatives, and direct the Company’s scientific work performed in support of world-wide regulatory submissions and claims substantiation. These efforts, and her outside work with standards setting organizations, such as AOAC’s CASP group demonstrates the Company’s continued commitment to providing its consumers with products that meet the highest regulatory standards for quality and safety.

Product Type
On Demand

Emerging Cannabinoids: Unique Legal and Regulatory Issues


Average Rating:
Not yet rated
Category:
Emerging Cannabinoids |  Cannabis |  Cannabis Science
Faculty:
Neil Willner |  Shawn Hauser |  Rod Kight |  Sibyl Swift
Duration:
1 Hour
Format:
Audio and Video
SKU:
INCBA09302022emercannOD
License:
Access for 6 month(s) after purchase.
Short Description:
This panel will provide real life practical solutions to the question the cannabis industry faces: how do we level the playing field in a highly regulated, highly competitive industry? We will discuss...
Price:
$75.00 - Non Member Price

Showing 1 to 1 of 1 entries